These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33559527)

  • 1. Oncological and Functional Outcomes of Patients Undergoing Individualized Partial Gland Cryoablation of the Prostate: A Single-Institution Experience.
    Tan WP; Chang A; Sze C; Polascik TJ
    J Endourol; 2021 Sep; 35(9):1290-1299. PubMed ID: 33559527
    [No Abstract]   [Full Text] [Related]  

  • 2. Oncological and functional outcomes of men undergoing primary whole gland cryoablation of the prostate: A 20-year experience.
    Tan WP; Kotamarti S; Chen E; Mahle R; Arcot R; Chang A; Ayala A; Michael Z; Seguier D; Polascik TJ
    Cancer; 2022 Nov; 128(21):3824-3830. PubMed ID: 36107496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncological and Functional Outcomes for Men Undergoing Salvage Whole-gland Cryoablation for Radiation-resistant Prostate Cancer.
    Tan WP; Kotamarti S; Ayala A; Mahle R; Chen E; Arcot R; Chang A; Michael Z; Seguier D; Polascik TJ
    Eur Urol Oncol; 2023 Jun; 6(3):289-294. PubMed ID: 36890104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage Prostate Cryoablation for the Management of Local Recurrence After Primary Cryotherapy: A Retrospective Analysis of Functional and Intermediate-Term Oncological Outcomes Associated With a Second Therapeutic Freeze.
    Aminsharifi A; Jibara G; Tsivian E; Tsivian M; Elshafei A; Polascik TJ
    Clin Genitourin Cancer; 2019 Aug; 17(4):e831-e836. PubMed ID: 31213413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
    Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
    J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of Oncological and Functional Outcomes Between Primary Whole-Gland Cryoablation and High-Intensity Focused Ultrasound for Localized Prostate Cancer.
    Liu YY; Chiang PH
    Ann Surg Oncol; 2016 Jan; 23(1):328-34. PubMed ID: 26088651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anterior gland focal cryoablation: proof-of-concept primary prostate cancer treatment in select men with localized anterior cancers detected by multi-parametric magnetic resonance imaging.
    Sze C; Tsivian E; Tay KJ; Schulman AA; Davis LG; Gupta RT; Polascik TJ
    BMC Urol; 2019 Dec; 19(1):127. PubMed ID: 31805908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole and hemi-gland cryoablation for primary localized prostate cancer: Short and medium-term oncological and functional outcomes.
    Bossier R; Sanguedolce F; Territo A; Vanacore D; Martínez C; Regis F; Gallioli A; Mercade A; Mosquera L; Aumatell J; Balana J; Carlderon J; Huguet J; Gaya JM; Palou J; Breda A
    Actas Urol Esp (Engl Ed); 2020 Apr; 44(3):172-178. PubMed ID: 32033834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement.
    Deivasigamani S; Kotamarti S; Rastinehad AR; Salas RS; de la Rosette JJMCH; Lepor H; Pinto P; Ahmed HU; Gill I; Klotz L; Taneja SS; Emberton M; Lawrentschuk N; Wysock J; Feller JF; Crouzet S; Kumar M P; Seguier D; Adams ES; Michael Z; Abreu A; Jack Tay K; Ward JF; Shinohara K; Katz AE; Villers A; Chin JL; Stricker PD; Baco E; Macek P; Ahmad AE; Chiu PKF; Crawford ED; Rogers CG; Futterer JJ; Rais-Bahrami S; Robertson CN; Hadaschik B; Marra G; Valerio M; Chong KT; Kasivisvanathan V; Tan WP; Lomas D; Walz J; Guimaraes GC; Mertziotis NI; Becher E; Finelli A; Kasraeian A; Lebastchi AH; Vora A; Rosen MA; Bakir B; Arcot R; Yee S; Netsch C; Meng X; de Reijke TM; Tan YG; Regusci S; Benjamin TGR; Olivares R; Noureldin M; Bianco FJ; Sivaraman A; Kim FJ; Given RW; Dason S; Sheetz TJ; Shoji S; Schulman A; Royce P; Shah TT; Scionti S; Salomon G; Laguna P; Tourinho-Barbosa R; Aminsharifi A; Cathelineau X; Gontero P; Stabile A; Grummet J; Ledbetter L; Graton M; Stephen Jones J; Polascik TJ;
    Eur Urol; 2023 Dec; 84(6):547-560. PubMed ID: 37419773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal cryoablation: a treatment option for unilateral low-risk prostate cancer.
    Durand M; Barret E; Galiano M; Rozet F; Sanchez-Salas R; Ahallal Y; Macek P; Gaya JM; Cerruti J; Devilliers H; Loeffler J; Amiel J; Vallancien G; Cathelineau X
    BJU Int; 2014 Jan; 113(1):56-64. PubMed ID: 24053685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: initial results from the cryo on-line data registry.
    Li YH; Elshafei A; Agarwal G; Ruckle H; Powsang J; Jones JS
    Prostate; 2015 Jan; 75(1):1-7. PubMed ID: 25283814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy.
    de Castro Abreu AL; Bahn D; Leslie S; Shoji S; Silverman P; Desai MM; Gill IS; Ukimura O
    BJU Int; 2013 Aug; 112(3):298-307. PubMed ID: 23826840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Focal Versus Whole Gland Ablation for Prostate Cancer on Sexual Function and Urinary Continence.
    Borges RC; Tourinho-Barbosa RR; Glina S; Macek P; Mombet A; Sanchez-Salas R; Cathelineau X
    J Urol; 2021 Jan; 205(1):129-136. PubMed ID: 33119421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage partial gland ablation for recurrent prostate cancer following primary partial gland ablation: Functional and oncological outcomes.
    Qaoud Y; Herrera-Caceres JO; Bass R; Berjaoui MB; Tiwari R; Kenk M; Lajkosz K; Finelli A; Perlis N; Klotz L; Fleshner N
    Urol Oncol; 2022 Jul; 40(7):343.e1-343.e6. PubMed ID: 35537905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of functional and oncological outcomes of localized prostate cancer after different minimally invasive therapeutic methods: A single center experience.
    Chinenov DV; Shpot EV; Chernov YN; Gerasimov AN; Kazachevskaya LY; Lyapichev KA; Ismailov HM; Tsukkiev ZK; Korolev DO; Rapoport LM
    Urologia; 2024 May; 91(2):311-319. PubMed ID: 38247121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal Cryoablation of Image-Localized Prostate Cancer.
    Arcot R; Potts BA; Polascik TJ
    J Endourol; 2021 Sep; 35(S2):S17-S23. PubMed ID: 34499551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years.
    Bahn D; de Castro Abreu AL; Gill IS; Hung AJ; Silverman P; Gross ME; Lieskovsky G; Ukimura O
    Eur Urol; 2012 Jul; 62(1):55-63. PubMed ID: 22445223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal cryosurgical ablation of the prostate: a single institute's perspective.
    Hale Z; Miyake M; Palacios DA; Rosser CJ
    BMC Urol; 2013 Jan; 13():2. PubMed ID: 23311921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cryosurgery of the prostate for nonsurgical candidates.
    Al Ekish S; Nayeemuddin M; Maddox M; Pareek G
    JSLS; 2013; 17(3):423-8. PubMed ID: 24018080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Outcomes Between Preoperatively Potent Men Treated with Focal Versus Whole Gland Cryotherapy in a Matched Population.
    Mendez MH; Passoni NM; Pow-Sang J; Jones JS; Polascik TJ
    J Endourol; 2015 Oct; 29(10):1193-8. PubMed ID: 26058496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.